AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Virax Biolabs Group Limited Statistics
Share Statistics
Virax Biolabs Group Limited has 4.34M shares outstanding. The number of shares has increased by 139.68% in one year.
Shares Outstanding | 4.34M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 4.05M |
Failed to Deliver (FTD) Shares | 21.40K |
FTD / Avg. Volume | 1.18% |
Short Selling Information
The latest short interest is 446.54K, so 10.28% of the outstanding shares have been sold short.
Short Interest | 446.54K |
Short % of Shares Out | 10.28% |
Short % of Float | 11.01% |
Short Ratio (days to cover) | 0.11 |
Valuation Ratios
The PE ratio is -0.22 and the forward PE ratio is -1.09.
PE Ratio | -0.22 |
Forward PE | -1.09 |
PS Ratio | 9.43 |
Forward PS | 0.8 |
PB Ratio | 0.27 |
P/FCF Ratio | -0.2 |
PEG Ratio | n/a |
Enterprise Valuation
Virax Biolabs Group Limited has an Enterprise Value (EV) of -1.81M.
EV / Earnings | 0.27 |
EV / Sales | -11.6 |
EV / EBITDA | 0.27 |
EV / EBIT | 0.28 |
EV / FCF | 0.24 |
Financial Position
The company has a current ratio of 25.94, with a Debt / Equity ratio of 0.
Current Ratio | 25.94 |
Quick Ratio | 25.58 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -241.7 |
Financial Efficiency
Return on equity (ROE) is -1.25% and return on capital (ROIC) is -121.13%.
Return on Equity (ROE) | -1.25% |
Return on Assets (ROA) | -1.23% |
Return on Capital (ROIC) | -121.13% |
Revenue Per Employee | 9.20K |
Profits Per Employee | -396.09K |
Employee Count | 17 |
Asset Turnover | 0.03 |
Inventory Turnover | 1.75 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 92.13% in the last 52 weeks. The beta is 1.93, so Virax Biolabs Group Limited's price volatility has been higher than the market average.
Beta | 1.93 |
52-Week Price Change | 92.13% |
50-Day Moving Average | 1.99 |
200-Day Moving Average | 1.71 |
Relative Strength Index (RSI) | 61.58 |
Average Volume (20 Days) | 1.81M |
Income Statement
In the last 12 months, Virax Biolabs Group Limited had revenue of 156.42K and earned -6.73M in profits. Earnings per share was -3.36.
Revenue | 156.42K |
Gross Profit | 50.59K |
Operating Income | -6.50M |
Net Income | -6.73M |
EBITDA | -6.61M |
EBIT | -6.50M |
Earnings Per Share (EPS) | -3.36 |
Balance Sheet
The company has 3.59M in cash and 224.30K in debt, giving a net cash position of 3.36M.
Cash & Cash Equivalents | 3.59M |
Total Debt | 224.30K |
Net Cash | 3.36M |
Retained Earnings | -18.53M |
Total Assets | 5.48M |
Working Capital | 4.21M |
Cash Flow
In the last 12 months, operating cash flow was -6.25M and capital expenditures -1.16M, giving a free cash flow of -7.41M.
Operating Cash Flow | -6.25M |
Capital Expenditures | -1.16M |
Free Cash Flow | -7.41M |
FCF Per Share | -3.69 |
Margins
Gross margin is 3.23K%, with operating and profit margins of -415.32K% and -430.48K%.
Gross Margin | 3.23K% |
Operating Margin | -415.32K% |
Pretax Margin | -430.84K% |
Profit Margin | -430.48K% |
EBITDA Margin | -4.23K% |
EBIT Margin | -4.15K% |
FCF Margin | -4.74K% |
Dividends & Yields
VRAX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -137.7% |
FCF Yield | -69.96% |
Analyst Forecast
Currently there are no analyst rating for VRAX.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 18, 2023. It was a backward split with a ratio of 1:10.
Last Split Date | Dec 18, 2023 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | 2.01 |
Piotroski F-Score | 3 |